Zelira Therapeutics Ltd
ASX:ZLD ISIN:AU000000ZLD1
Zelira Therapeutics Ltd (ASX:ZLD) (OTCMKTS:ZLDAF) is a leading global cannabinoid-based biopharmaceutical company with access to the world's largest and fastest growing markets. Zelira owns a portfolio of proprietary revenue generating products and a pipeline of candidates undergoing clinical development that are positioned to enter global markets. The Company is focused on developing branded cannabinoid-based medicines for the treatment of a variety of medical conditions in its Rx business, including insomnia, autism and chronic non-cancer pain.
News
The Directors of Chapmans Limited (ASX:CHP) are pleased to announce that the Company has successfully completed it's strategic investment in MJ Life Sciences Pty Ltd referred to in the Company's previous announcements of 23 and 29 August.
The Directors of Chapmans Limited (ASX:CHP) are pleased to announce that the Company has entered into a Binding Heads of Agreement with MJ Life Sciences Pty Ltd, to make a strategic investment of US$500,000 in MJLS.
The Directors of Chapmans Limited (ASX:CHP) (Chapmans, the Company) are pleased to provide the following update on it's investments and activities.
The Directors of Chapmans Limited (ASX:CHP) are pleased to announce that its specialist wholly owned medicinal cannabis subsidiary, Cannabis Investments Limited, has entered into a Term Sheet with AZ Pharmaceuticals Inc., the owner of the Aunt Zelda's medicinal cannabis business, to invest USD 2 million in Aunt Zelda's.
GLENEAGLE GOLD LIMITED (ASX: GLN) - Development on Track at the Fortnum Gold Project - Mr Ian Prentice, Managing Director; Boardroomradio is pleased to announce that GLENEAGLE GOLD LIMITED (ASX: GLN)
###
5,293 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 7) (Last 30 Days: 39) (Since Published: 5293)
